NEW HOPE, PA — Orchestra BioMed Holdings Inc. (Nasdaq: OBIO) received a $6.1 million milestone payment Sept. 14 tied to Haemonetics Corp.’s acquisition of Vivasure Medical Limited, lifting its cash …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.